Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence.

Liu TT, Wilson D, Dawood H, Cameron DW, Alvarez GG.

Clin Dev Immunol. 2012;2012:937013. doi: 10.1155/2012/937013. Epub 2012 Mar 19.

PMID:
22474486
2.

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS.

Int J Tuberc Lung Dis. 2012 Jan;16(1):90-7. doi: 10.5588/ijtld.11.0153.

PMID:
22236852
3.

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH; Tugela Ferry Care and Research (TF CARES) Collaboration.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. doi: 10.1164/rccm.200907-0989OC. Epub 2009 Oct 15.

PMID:
19833824
4.

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.

PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.

PMID:
23762367
5.

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.

PMID:
21943840
6.

Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.

Hicks RM, Padayatchi N, Shah NS, Wolf A, Werner L, Sunkari VB, O'Donnell MR.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1074-83. doi: 10.5588/ijtld.14.0231.

PMID:
25189555
7.

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2.

PMID:
23032215
8.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
9.

Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.

Schreiber YS, Herrera AF, Wilson D, Wallengren K, Draper R, Muller J, Dawood H, Doucette S, Cameron DW, Alvarez GG.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1274-80.

PMID:
19793433
10.

HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.

Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J.

J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.

PMID:
19886382
11.

Predictors and mortality associated with treatment default in pulmonary tuberculosis.

Kliiman K, Altraja A.

Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

PMID:
20202304
12.

High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.

Fairlie L, Beylis NC, Reubenson G, Moore DP, Madhi SA.

BMC Infect Dis. 2011 Jan 26;11:28. doi: 10.1186/1471-2334-11-28.

PMID:
21269475
13.

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.

Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.

Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.

PMID:
23321297
14.

Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis.

Kang MW, Kim HK, Choi YS, Kim K, Shim YM, Koh WJ, Kim J.

Ann Thorac Surg. 2010 May;89(5):1597-602. doi: 10.1016/j.athoracsur.2010.02.020.

PMID:
20417785
15.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
16.

[Death due to tuberculosis requiring treatment or an accompanying disease? A contribution to the lethality and mortality of tuberculosis in Germany].

Forssbohm M, Kropp R, Loytved G, Neher A, Simma M, Rabbow M, Becher H.

Pneumologie. 2011 Oct;65(10):607-14. doi: 10.1055/s-0030-1256805. Epub 2011 Oct 20. German.

PMID:
22015487
17.

High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting.

Lui G, Wong RY, Li F, Lee MK, Lai RW, Li TC, Kam JK, Lee N.

PLoS One. 2014 Mar 18;9(3):e92077. doi: 10.1371/journal.pone.0092077. eCollection 2014.

PMID:
24642794
18.

Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.

Churchyard GJ, Corbett EL, Kleinschmidt I, Mulder D, De Cock KM.

Int J Tuberc Lung Dis. 2000 May;4(5):433-40.

PMID:
10815737
19.

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.

Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, Boulle A, Goemaere E, van Cutsem G.

Int J Tuberc Lung Dis. 2014 Apr;18(4):441-8. doi: 10.5588/ijtld.13.0742.

PMID:
24670700
20.

The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33. doi: 10.5588/ijtld.11.0679. Epub 2012 May 8.

PMID:
22583610

Supplemental Content

Support Center